Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Genentech |
---|---|
Information provided by: | Genentech |
ClinicalTrials.gov Identifier: | NCT00097552 |
This study is a multicenter, open-label, observational, postmarketing surveillance study of Genentech growth hormone (GH) products in the treatment of girls with Turner syndrome in the United States and Canada.
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS) |
Ages Eligible for Study: | up to 17 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Primary care clinic
Inclusion Criteria:
Exclusion Criteria:
Contact: Trial Information Support Line | 800-723-6247 |
United States, California | |
Trial Information Support Line | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact 800-723-6247 |
Study Director: | Barbara Lippe, M.D. | Genentech |
Responsible Party: | Genentech, Inc. ( Clinical Trials Posting Group ) |
Study ID Numbers: | 85-036, Substudy 9 |
Study First Received: | November 24, 2004 |
Last Updated: | July 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00097552 |
Health Authority: | United States: Institutional Review Board |
Chromosomal abnormalities Genital dwarfism Gonadal Disorders Chromosome Disorders Endocrine System Diseases Sex Differentiation Disorders Monosomy X Turner Syndrome |
Gonadal dysgenesis Urogenital Abnormalities Genetic Diseases, Inborn Turner syndrome Ovarian dwarfism Endocrinopathy Congenital Abnormalities Gonadal Dysgenesis |
Pathologic Processes Disease Syndrome Sex Chromosome Disorders |